Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer
- 1 March 2001
- Vol. 57 (3) , 481-485
- https://doi.org/10.1016/s0090-4295(00)01039-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- CLINICAL AND PATHOLOGICAL CHARACTERISTICS, AND RECURRENCE RATES OF STAGE T1C VERSUS T2A OR T2B PROSTATE CANCERJournal of Urology, 1999
- Biological Determinants of Cancer Progression in Men With Prostate CancerJAMA, 1999
- THE CHANGING PATTERN OF PROSTATE CANCER AT THE TIME OF DIAGNOSIS: CHARACTERISTICS OF SCREEN DETECTED PROSTATE CANCER IN A POPULATION BASED SCREENING STUDYJournal of Urology, 1999
- Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.Mayo Clinic Proceedings, 1998
- Update on the Appropriate Staging Evaluation for Newly Diagnosed Prostate CancerJournal of Urology, 1997
- Prostate cancer diagnosis and managementThe Lancet, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen LevelJournal of Urology, 1996
- Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.Radiology, 1991